During the past decade, Synexus Clinical Research US, Inc conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 9 clinical trials were completed, i.e. on average, 31% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 9 clinical trials were completed. i.e. 39.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Allergan" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Janssen Vaccines & Prevention B.V." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc" are "Diabetic Peripheral Neuropathic Pain" (4 trials), "Chronic Low-back Pain" (3 trials), "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials) and "Osteoarthritis" (3 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc" in a lesser frequency.

Most popular intervention types in "Synexus Clinical Research US, Inc" are "Drug" (24 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "LY3016859" (3 trials), "LY3556050" (3 trials), "Relamorelin" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Clinical Research US, Inc" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Synexus Clinical Research US, Inc". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Synexus Clinical Research US, Inc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Clinical Research US, Inc, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".